外文报告-PDF版

CUJO：2020-2021年北美互联设备状况报告（英文版）（44页）.pdf

The State of Connected Devices in North America 2020/21 May 2021Our report provides a holistic analy.

2021-03-13 44页 5星级

谷歌&淡马锡：2020东南亚数字经济报告（英文版）（128页）.pdf

1Disclaimere-Conomy SEA is a multi-year research program launched by Google and Temasek in 2016.Bain.

2021-03-13 128页 5星级

UFI：2020年全球复苏洞察-Part 1：商业活动的前进方向（英文版）（20页）.pdf

Global Recovery Insights 2020www.ufi.org/researchSUPPORTED BY:PRODUCED BY:Part 1:The way forward for business eventsContentsSECTION 1SECTION 2SECTION 3SECTION 4SECTION 5SECTION 6SECTION 7SECTION 8SECTION 93467911131418WelcomeKey areas of focusKey findingsThe impact of event cancellationsFuture attendanceVisitor quality beats numbers for exhibitorsThe importance of networkingThe return of budgetsA position of strength2G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Dear industry colleagues,We are happy to publish the first part of this global study of both visitors and exhibitors,the latest in a series of reports we have produced in partnership with Explori.At the time of publishing in October we face a very uncertain picture ahead,however I am happy to see the responses which do not show a long term shift away from live events,and that this crisis is a temporary hurdle which we will overcome like we did with many previous challenges.Our audience appreciates the unique aspects of face-to-face for building human connections which serve them both personally and professionally.These have yet to be recreated effectively in digital events.This report is based on a quantitative survey of trade show visitors and exhibitors,with 9,000 responses in 10 languages representing trade show participation in over 30 countries.We have been able to make comparisons with our 2018 and 2019 Global Insights reports to assess the impact of the lack of events on visitors and exhibitors,and their plans to return to live events in 2021.The absence of live events has damaged not only our industry,but all industries by reducing their access to networking,lead generation and ultimately new business.We hope this study can demonstrate to policy makers,governments to support the safe return of live business events in the coming months.We will publish the second part of this report by the end of the year.If you have any feedback please contacts us at researchufi.orgAs we all make our way through this pandemic reading this report certainly reassured me once more of the critical role that our industry has to play,and of the fact that our customers see it the same way.Yours sincerely,Kai HattendorfUFI Managing Director/CEOWelcome3G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Key areas of focusComparisons with the 2018 and 2019 Global Insights where available-these reports are available to UFI members at www.ufi.org/researchFieldwork in July and August 2020A second phase of research will be conducted in December 2020 to determine any change in sentiment and the impact of budget planning for 2021.A quantitative survey of trade show visitors and exhibitors,gaining 9,000 responses,in 10 languages,representing trade show participation in over 30 countries.The impact of trade show cancellations on both visitors and exhibitors1.How exhibiting budgets might change and what is driving these decisions4.The views of both groups on their potential return2.What shows might have a more secure future than others5.What are the most important factors that would encourage customers to return3.Building on UFI and Exploris previous Global Visitor and Global Exhibitor Insight reports,this study investigates:MethodologyS E C T I O N 24G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Key FindingsFuture attendance There is no evidence in this study of a fundamental shift away from live events.Although intended frequency of participation has dropped for both groups,it has done so only marginally for exhibitors.Visitors are concerned about short term issues like safety and travel,but appreciate the important business benefits live events bring.Networking is keyThe social aspects of events remain a critical draw for both groups,who rely on live events to create connections within their communities.This is an aspect that is notably poorly served by digital events.Quality is kingThere is a clear message from visitors that quality of exhibitors is paramount,suggesting that those who plan to attend have strong buying intentions.Exhibitors plan to factor visitor quality far more highly in their decision making than visitor numbers.Budgets to return53%of exhibitors expect spend to return to pre-Covid levels within 12 months.28%reported their spend would return as soon as trade shows started running again.Whilst spend allocated to live events has been put on hold,overall marketing budgets had yet to see severe cuts as of late summer.Play it safe?Both visitors and exhibitors will look to previous experience with a show when deciding whether to return.They will turn to show brands they trust to deliver robust safety measures,but more importantly high quality audiences.Customers and industries miss live events The negative impact of the lack of live events is being widely felt by both visitors and exhibitors.Two thirds of those who exhibit at business events reported their cancellation has had a notable detrimental impact on their business,reducing their ability to build brand awareness with their target markets.Half of businesses expressed this impact as being“large”or“very large”.of companies told researchers that the absence of live events was negatively affecting their ability to generate new business.48%S E C T I O N 35G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0The impact of event cancellationsLive events are being sorely missed by the businesses who rely on them to connect with their customers:Almost half of those who exhibit at trade shows reported their cancellation has had a notable detrimental impact on their business,reducing their ability to build awareness with their target markets.43scribed this impact as being large or very large.Exhibitors:To what extent has the cancellation of the event(s)affected your business?Exhibitors:How has the cancellation and/or postponement of events at which you were due to exhibit affected your business?Almost half of companies reported that the absence of live events was negatively affecting their ability to generate new business.48%have generated fewer leads and 45%have seen a negative impact on their sales,through not being able to exhibit.S E C T I O N 46G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0How does this differ by region?Across many aspects of this study,the attitudes of exhibitors were strikingly similar.It can be seen that on average,the impact of event cancellations is most acutely felt in regions where the trade show industry is still developing.In comparison,regions where the sector is mature,such as North America and Europe,felt a lesser,but still notable impact.Visitors have also felt less connected to their communities without access to business events.90%reported being impacted in some way and over a quarter felt the impact to their business had been very large.To what extent has the cancellation of event(s)affected your business(1-5 scale with 5 being greatest impact)?Impact on visitorsWhilst many felt this impact in their limited access to networking and educational opportunities,almost a third also reported an impact on their ability to source new suppliers,again highlighting the role events play in generating business within the sectors they serve.To what extent has the cancellation/postponement of event(s)affected you and your business?90fected in some way1=No impact at all 5=Very large impact57G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Future attendanceBoth visitors and exhibitors reported some drop in how frequently they planned to attend live events in future compared to previous studies we have conducted.But when compared with data from 2019,the drop for exhibitors was very modest.This reduction in frequency seems to be part of a more long-term trend.In markets where the exhibition industry is more developed,exhibitors have indicated in previous studies that they are planning to level out their participation.The more pronounced impact on visitor attendance is driven by short term concerns,primarily around safety.Visitors who are planning to reduce their attendance need to be reassured that robust safety measures are in place.They are also more drawn to the option of being able to attend an event digitally,for the time being at least.Future exhibitor participationSo in the future,do you expect to exhibit at trade shows.S E C T I O N 58G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0The biggest three drivers of reduced future attendance for visitors are safety concerns(69%),travel restrictions(58%)and concerns about cancellations(34%).Very few(13%or less)cited more long term concerns such as lack of time or value as reasons for attending trade shows less frequently in future.So in the future,do you expect to attend trade shows.Reasons why visitors might attend less in future69V4%Safety concernsTravel restrictionsConcerns about possible cancellationsFuture visitor participation9G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0S E C T I O N 6Visitor quality beats numbers for exhibitorsVisitor quality is the biggest factor influencing the decision of exhibitors to return to a particular show.80%of respondents felt visitor quality had a large impact on their show selection,well ahead of price at 49%.It was also the aspect they wanted organisers to prioritise most,being selected by almost twice as many exhibitors as“visitor numbers”.This suggests that exhibitors will overlook smaller visitor numbers in the short-term as long as organisers can create a compelling story as to how they will attract the highest quality audience.Notably,only 3%of exhibitors felt there was nothing an organiser could do to encourage their return,suggesting that there is no sign of a fundamental shift away from live events at this stage.What are the main things trade show organisers should focus on to encourage you to exhibit at their shows?Recommended Priorities10G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Whilst many visitors want organisers to prioritise strict health and safety measures,interestingly exhibitor quality has surged in importance for them.1 in 3 visitors said exhibitor quality was the area that organisers should focus on most,making it the most significant factor,once hygiene aspects have been addressed.This suggests that visitors who are planning to attend a show are motivated buyers who need to be sure they will meet high quality suppliers who can address their business needs.The relative importance of quality educational content has dropped off vs.previous years,perhaps reflecting the strict business case needed to attend a trade show,or the emerging ability of digital events to provide high quality content.What are the main things trade show organisers should focus on to encourage you to attend their shows?Visitors Priorities for Organisers0103040205060 49H%Make the process of attending easier (registration,queues etc.)Increase exhibitornumbersEnable you to attendremotely/virtuallyContinue to provide in-person networking opportunitiesImprove exhibitorqualityReduce costs associated with attendingIntroduce strict Covid-19safety measures11G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0The importance of networkingWould the following measures make you more or less likely to exhibit at trade shows?Exhibitors Reject Measures That Impact NetworkingThrough many aspects of this study,the ability to connect face-to-face has been confirmed as the defining strength of the business events industry.S E C T I O N 7Whilst our audience is supportive of sensible health and safety measures,they are reluctant to accept any measures that impede their ability to network,telling us that any reduction on social and networking activity reduces their likelihood to attend an event.This presents a challenge for organisers and venues alike,who must balance social interaction with maintaining a Covid-secure environment.12G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 085%Live events betterWould the following measures make you more or less likely to attend at trade shows?Many Visitors Feel The Same.Reduced access to networking was cited as the biggest impact caused by the cancellation of business events and a priority for organisers when they return.Digital events are not currently filling this gap,with“quality of networking”being the area they scored most poorly in comparison to live events with only 8%of exhibitors and 7%of visitors feeling that digital could compete with live.86%Digital events betterDigital events betterLive events betterHow do digital events compare to live events for networking?8%EXHIBITORSVISITORS7G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0The return of budgetsS E C T I O N 8Most exhibitors expect their spend to return to pre-Covid levels in the short to medium term,with 28%stating that they were ready to spend immediately.The average expected return date was around 11 months after respondents took the survey in July/August 2020,which remained remarkably consistent across both sectors and geographies,regardless of how much they had been disrupted by the pandemic.When,if at all,do you expect your trade show exhibiting spend to return to pre-Covid levels?Most Spend to Return in 1-2 Show CyclesOnly 12%of exhibitors reported that their spend would never return to pre-Covid levels.12G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0When,if at all,do you expect your trade show exhibiting spend to return to pre-Covid levels?Budgets will be found by those who believe in live events as a channel Where will reductions come from?There was little difference by company size or sector between exhibitors whose budget would return immediately and those who felt the budget reduction was permanent.But what could be seen was how strongly each of these groups favoured trade shows as a channel to achieve particular objectives.Again,the ability to network is a strong driver here.Those who indicated trade shows were their preferred channel for networking or selling,were much more likely to make budget available than those who preferred other channels.This held true regardless of the extent to which those exhibitors were facing budgetary constraints,suggesting that those that value live events will continue to prioritise them in their spending.41%Trade shows best channel for SELLING192%Trade shows best channel for NETWORKING521C%Budget returns immediatelyBudget never fully returnsAverage15G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Since the start of the Covid-19 crisis,to what extent have your marketing budgets for the following channels changed?Dont know responses excluded from the analysisThe impact on marketing budgetsWhilst as of late summer,budgets for other marketing channels remained relatively unaffected,unsurprisingly there has been a big impact on spend for live events.Both trade show spend and in-house event spend have effectively halved at this time.This will require further investigation in the second wave of research to understand how budgets are affected by 2021 business planning.There was notably little difference in budget impact between sectors.Jewelry and Aviation reported some of the biggest reductions in their planned live event spend(58 and 54%).Whereas the comparatively less affected sectors of Agriculture and Utilities still reported cut-backs of 45%.16G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0Are exhibitors more likely to drop shows from their plans as budget pressure increases?Spread your budget or drop a show?To what extent do the following factors influence your decision to exhibit at or sponsor a show?How will exhibitors decide where to spend?As we have seen in previous sections,exhibitors will prioritise events that can deliver a high quality visitor and meaningful opportunities to network.They are likely to accept reduced visitor numbers where they are confident that they will be able to get face-to-face with key buyers.But how will they make this judgement?Previous experience at an event will be a powerful decision making factor,more than twice as important as a recommendation from a colleague or peer.Exhibitors will be looking to the show brands they already trust to deliver the quality audience they need.Conversely they may be less likely to experiment with emerging shows,or those they have not had personal experience of before.Encouragingly,it seems that trusted shows who can create a compelling quality proposition may experience less price sensitivity from their exhibitors.Will these budget cuts manifest themselves in shows being dropped from a trade show marketers plans,or an overall belt-tightening?The picture is complex.Whilst we can definitely see that the more severe the budget cut,the more likely an exhibitor is to reduce the number of shows they support,it is also true that,even for companies experiencing the largest cuts to their trade show budgets(in excess of 50%)they are still equally likely to continue to exhibit as frequently as to start dropping shows.-60-40020-20406080%AverageNo budget changeCut up to 50%Cut more than 50%Exhibit less frequentlyExhibit as frequently17G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0A position of strengthTrusted Brand We can see that previous(positive)experience is a critically important factor for both visitors and exhibitors in deciding whether to participate in a show.Shows with high Net Promoter ScoresTM and high loyalty scores in their customer satisfaction studies are strongly placed here.Visitors are also prioritising shows that can attract the highest quality exhibitors,perhaps favouring those holding a market leading position.Shows that have historically rated highly for“importance”are likely to be trusted by customers in this aspect.Oriented towards networking and deal-making Both visitors and exhibitors value the face-to-face networking opportunities of business events.In addition visitors are looking to build a strong business case for attending as budgets receive more scrutiny.Therefore shows that have previously seen networking and commercial objectives given high importance by visitors and exhibitors and have a track record of meeting these objectives,will be very strongly placed to welcome back their audience.However shows that have previously focused more on content,education and branding objectives may need to re-visit their proposition to remain relevant and to compete with digital offerings.Flexible approach to total cost of exhibiting Many exhibitors will be looking to reduce their total cost of exhibiting.Whilst they may be looking to organisers for discounts,they will also be looking to suppliers and accommodation providers.Shows that can manage this in a collaborative way and offer flexible solutions that benefit the long-term relationship with the exhibitor are likely to be viewed more favourably than those who take a more rigid approach.Low dependence on international travelWhilst not generally prohibited by company policy,many visitors and exhibitors have concerns about travel disruption when participating in overseas events.Therefore measures such as travel corridors and priority status for business travellers are important protective factors.However,international travellers within and to Asia are already showing greater confidence than their peers who would normally travel into North America and into/within Europe.A compelling proposition for those who wish to attend digitally may also be an important factor in retaining international visitors(and domestic visitors)who have heightened concerns about travel safety.Makes the business case for visitors In addition to seeing the sectors leading brands,visitors are likely to be seeking out the most innovative suppliers to meet their business needs,which could have changed dramatically since the last edition of the show.Show teams that have a clear understanding of the changing needs of the sectors they serve,combined with a robust process for identifying and attracting the most innovative players in the market(including start-ups and new entrants),will be able to create the most compelling visitor propositions.With many sectors seeing unprecedented change,an agile approach with clear focus on solutions on a new way of working could be an important factor in helping less established shows compete against market leaders.If sector and geography appear to make relatively little difference to attitudes of visitors and exhibitors,what are the factors that would suggest that a show is in a relatively robust position as live events return?It seems that the most important factors are inherent to the show itself-how well it has previously performed in the eyes of its customers and how well the show team can align with the changing needs of the market they serve.S E C T I O N 918G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0About ExploriReport authorsSuzanne Van MontfoortResearch Director(Bespoke),ExploriChristian DruartResearch Manager,UFISophie HoltManaging Director,Explori The official research partner of UFIThank you to all research participantsUFI Diamond SponsorsUFI Research PatronUFI and Explori would like to thank the trade show organisers and UFI members and partners who supported the wide collection of data that made this research possible.The authors also wish to thank the research teams at Explori,GRS and GRS Explori,and in particular Charlotte Penn and Mitch Deeming for the significant work that has gone in to producing this report.Explori provides scalable research solutions for exhibition organisers all over the world.With a global client base including Hyve,Clarion Events,Informa,Comexposium,Messe Frankfurt,Emerald,Diversified Communications and many others contributing to their global data set of industry benchmarks.Exploris research platform is designed to support organisers in gathering meaningful customer experience insight across multiple territories and languages.Over 3,000 events worldwide now work with Explori including trade shows,digital events and conferences.As part of their partnership with UFI,Explori produces annual reports giving insight into the customer experience of visitors and exhibitors across the industry.Explori is independently owned by its founders,directors and employees and is headquartered in London.19G LO B A L R E C O V E R Y I N S I G H T S 2 0 2 0UFI is the leading global association of the worlds tradeshow organisers and exhibition centre operators,as well as the major national and international exhibition associations,and selected partners of the exhibition industry.UFIs main goal is to represent,promote and support the business interests of its members and the exhibition industry.UFI directly represents around 50,000 exhibition industry employees globally,and also works closely with its 54 national and regional associations members.Around 800 member organisations in 87 countries and regions around the world are presently signed up as members.Around 1,000 international trade fairs proudly bear the UFI approved label,a quality guarantee for visitors and exhibitors alike.UFI members continue to provide the international business community with a unique marketing media aimed at developing outstanding face-to-face business opportunities.www.ufi.orgAbout UFIThe Global Association of the Exhibition Industry

2021-03-13 20页 5星级

Trados：2020年GroupShare 技术白皮书（英文版）（12页）.pdf

SDL Trados GroupShare 2020This document describes the functionality and technology behind SDL Trados.

2021-03-13 12页 5星级

英国能源网络协会：2020年英国天然气网络创新战略报告（英文版）（25页）.pdf

Gas Network Innovation StrategyThe Voice of the NetworksMarch 2020Foreword.03Introduction.04Our stra.

2021-03-13 25页 5星级

国际移民组织（IOM）：世界移民报告2020（英文版）（498页）.pdf

WORLD MIGRATION REPORT 2020 The opinions expressed in the report are those of the authors and do not.

2021-03-13 498页 5星级

伟凯：2020外商直接投资回顾：全球视野（英文版）（72页）.pdf

National security reviews 2020:AglobalperspectiveA guide to navigating the rules for investing in co.

2021-03-13 72页 5星级

Brightspot：2020无头CMS和GraphQL指南（英文版）（17页）.pdf

Brightspot eBook October 2020Guide to Headless CMS&GraphQLDeep Dive into Headless CMS Architecture a.

2021-03-13 17页 5星级

Activate Consulting：2020年顶级技术和媒体发展趋势报告（英文版）（196页）.pdf

ACTIVATE TECHNOLOGY&MEDIA OUTLOOK 2020 1Welcome to Activate Consultings Technology and Media Outlook.

2021-03-13 196页 5星级

Medtech Europe：2020年欧洲体外诊断(IVD)市场数据统计报告（英文版）（13页）.pdf

European IVD MarketStatistics Report11,10011,20011,30011,26511,40011,00010,90010,80010,70010,60010,50020092010201120122013201420152016201720182019EUROPEAN IVD MARKET REVENUES(MILLION)OverviewMedTech Europe is pleased to publish the market estimates of the In vitro diagnostic(IVD)industry in Europe.The MedTech Europe figures include market size and dynamics information,based on 2019 and 2018 data.Macroeconomic and healthcare data are also included for all 28 EU-member states plus the European Free Trade Association members(EFTA)Switzerland,Norway and Iceland.In vitro diagnostics(IVDs)are an essential part of todays healthcare.IVDs are used to diagnose,monitor,screen and assess predispositions to diseases,thereby contributing to the available medical information regarding a patient.By allowing earlier and more targeted treatments,IVDs help to reduce hospital stays and convalescences,resulting in healthier populations,reduced costs and economic growth in the long run.Three out of the five largest European IVD markets France,Spain and UK are showing slight to moderate growth in 2019 and overall revenues across EU-28 plus EFTA reached 11,265 million,an increase of 1.5%.If changes in the value of non-Euro currencies,are considered the overall change in the Euro value of the European IVD market from 2018 to 2019 is 1.3%.The IVD revenues in Germany stagnated(-0.4%),further market decrease was seen in the reagents market(-1.2%).In Italy,the IVD market decreased(-2%),with decreased revenues in both clinical chemistry,(-7.6%)and haematology,(-2.7%).From the largest five markets,the UK is experienced the highest increase of 3.1%,largely due to increase in instruments and consumables,infectious disease testing,and nucleic acid testing systems.In Spain,the IVD market increased by 2.8%due to growth in immunochemistry,micro and infectious diseases segments.After stagnation in 2015 and 2016,the French IVD market registered a third year of slight growth of 0.3%.The changes in revenues do not necessarily reflect changes in test volumes,and there is evidence in many countries that volumes have increased significantly without increased revenues.The Greek market marked an increase of 3.7%,the highest growth since 2008.On the other hand,Portugal reported a-1.5crease in IVD expenditure.In the newer EU member states,IVD expenditure averaged 1.2%of total healthcare expenditure(THE),significantly higher than the 0.63%seen in older member states(EU-15),but in absolute terms the new member states spend only 11.3 per capita compared to 23 in the EU-15.Growth in those states is at 6.4%compares to 0.8%in the EU-15 states.11,10011,20011,30011,26511,40011,00010,90010,80010,70010,60010,50020092010201120122013201420152016201720182019EUROPEAN IVD MARKET REVENUES(MILLION)OverviewCountrySpecificDataCountriesPopulation GDPGDP/capita THETHE/capita THE as%GDPIVD mkt.2019IVD mkt.2018IVD mkt.growth rate 19-18IVD mkt./THEIVD mkt./capita1000Mio Mio%Mio Mio%Germany83.0193.449.05041.545383.6364.62711,5%2.1612.170-0,4%0,6&,0France 167.0132.425.70836.198265.7643.96911,3%1.6231.6190,3%0,6$,2UK 266.6472.522.71337.852242.3003.64610,0%1.0421.0113,1%0,4,6Italy60.3601.789.74729.651153.0852.5348,7%1.5561.588-2,0%1,0%,8Spain46.9371.244.77226.520108.1102.3109,0%1.0331.0042,8%0,9,0Netherlands17.282810.24746.88377.2024.48010,0)42862,7%0,4,0Greece10.725183.41417.10214.2511.3287,7!31987,5%1,4,8Portugal10.277213.30120.75619.3031.8779,56229-1,5%1,2,0Belgium11.456476.20341.57047.4174.15010,3993863,3%0,84,8Sweden10.230474.46846.37951.2965.04110,971794,5%0,3,2Austria8.859397.57544.87939.7914.50110,3&82622,3%0,70,3Denmark5.806312.74753.86530.4505.25610,151512,8%0,5&,7Finland5.518240.55643.59521.1173.8299,09120-1,2%0,6!,5Ireland4.904356.05172.60122.4524.6136,961223,7%0,5%,7Luxembourg61463.516103.4653.1745.2215,3190,0%0,60,9EU-15409.64614.960.06936.5201.479.3493.6119,9%9.4199.3430,8%0,6#,0Poland37.973532.32914.01931.5028306,3943774,4%1,2,4Romania19.414223.33711.50411.3715845,651808,1%1,6,0Czech Rep10.650223.94521.02815.8721.4937,7215815,0%1,0,1Hungary9.773146.06214.9468.9649176,7795,1%0,9%8,4Bulgaria7.00061.2408.7484.1215877,4032-7,4%0,8%4,3Slovakia5.45093.86517.2225.9911.1006,7w761,9%1,3,2Croatia4.07654.23813.3063.5248626,8g654,4%1,8,5Lithuania2.79448.79717.4642.9731.0616,61299,3%1,0,3Latvia1.92030.46315.8671.8049366,202424,3%1,3,5Slovenia2.08148.39323.2563.7971.8318,3R520,1%1,4%,0Estonia1.32528.11221.2201.7351.3126,7!21-0,8%1,2,1Cyprus87622.28725.4451.4311.6456,8105,3%0,7,4Malta49413.46227.2761.1102.2909,0U0,0%0,5,1New MS103.8261.526.53114.70394.1949076,2%1.1771.1086,3%1,2,3EU-28(EU-15 new MS)513.47216.486.60032.1081.573.5433.0659,5.59610.4511,4%0,7 ,6Switzerland8.545653.47176.47870.9028.32711,9G34622,2%0,7U,3Norway5.328360.30167.62136.9716.96010,151783,8%0,54,7Iceland35721.63560.6041.8625.2808,5110,0%0,60,8EFTA14.2301.035.40772.764109.7357.71210,6f86512,6%0,6G,0TOTAL(EU-28 EFTA)527.70117.522.00733.2041.683.2783.1909,6.26511.1021,5%0,7!,3Turkey 82.004679.5108.28627.7013384,1%N/A645N/A2,3%N/ATOTAL(EU-28 EFTA Turkey)609.70518.201.51829.8531.710.9792.8069,4%N/A11.748N/A0,7%N/AEurostat 2019Eurostat 2018Source MedTech EuropeUKGBP1,13991,1304914 887 1.042 1.002 3,9%SwedenSEK0,094460,097521.975 1.891 187 184 1,2nmarkDKK0,1339390,1341711.159 1.128 155 151 2,5%EU-15EURN/AN/A9.419 9.341 0,8%PolandPLN0,23270,23471.678 1.608 390 377 3,5%RomaniaRON0,21070,2149906 840 191 180 5,7%Czech RepCZK0,038960,038994.664 4.057 182 158 15%HungaryHUF0,0030750,00313726.739 25.681 82 81 2,1%BulgariaBGN0,5113050,51130560 64 30 32 -7,4%CroatiaHRK0,1340,134502 481 67 65 4,4%New MSEURN/AN/A1.169 1.110 5,3%EU-28(EU-15 new MS)EURN/AN/A10.588 10.451 1,3%CountryCurrency2019 average Exchange Rate2018 average Exchange RateIVD mkt.2019 Mio LCIVD mkt.2018Mio IVD mkt.growth rate 19-18IVD mkt.2018 Mio LCIVD mkt.2019Mio IVD Market StatisticsThe applied exchange rates are the 2019 annual average exchange rates published by The European Central Bank.Applying a single exchange rate to both 2019 and 2018 sales data eliminates possible fluctuations of market size and market growth due to exchange variations.The impact of these fluctuations is shown in the table below.During the collection of 2019 years figures,the 2018 market size was re-estimated at the same time.That,together with the use of a single exchange rate,explains why some countries show different revenues compared to the figures presented in last years report for 2018.The growth rate between 2019 and 2018 has been calculated using the re-estimated figures.The data regarding population,GDP and healthcare expenditure are the latest available from Eurostat.IVD Market Size in EUR(using actual exchange rates)1 France data includes only the Central Laboratory IVD Market.2 UK data reflects the consolidated sales of the participating companies in GDMS,plus the figures published by NHS England for glucose test strip sales adjusted to represent the whole of the UK.CountrySpecificDataAlthough there are variations in healthcare systems,reimbursement policies etc.from country to country,healthcare cost containment is a constant across the various countries in this report.Besides budget restrictions,greater centralization both in the public and private laboratory sectors has increased the power of purchasing organizations.The overall situation with Sales Outstanding(DSO)in 2019 remains unsatisfactory.2019 IVDMarket Sizein mEUR2019 IVDMarket/Capitain EURSwitzerland 55Belgium 35Norway 35Luxembourg 31Iceland 31Austria 30Germany 26Italy 26Ireland 26Slovenia 25France 24Spain 22Portugal 22Finland 22Greece 20Sweden 18Czech Republic 17Netherlands 17Estonia 16Croatia 17UK 16Latvia 15Slovakia 14Cyprus 11Lithuania 11Poland 10Malta 10Romania 10Hungary 8Bulgaria 4Denmark 27The differences in total healthcare expenditure,both in relative terms to GDP and absolute amounts,demonstrate the wide variation in access to healthcare across the thirty-one countries in this report.Relative to GDP Switzerland is the leading country at 11.9%,followed by Germany,France and Sweden.In absolute amounts the healthcare expenditure per capita Switzerland remains in first position,followed by Norway,Iceland,Denmark,Luxemburg,and Sweden.The IVD per capita expenditure also shows a wide variation from a low of 4.2 in Bulgaria to 55.2 in Switzerland,which remains also the leading country.Germany -0.4%IVD MARKET 2161 M EUR “The German IVD market continues with a slight decrease.The total IVD market 2019 is estimated at 2.161 billion euros.This represents a market decline of 0.4%compared to the previous year.The reagents market fell by 1.2%,while the market for instruments(including services,spare parts and supporting software)grew by 4.2%.Looking at the different market segments the laboratory market(reagents and instruments)grew by 2.0%.Some of the effects of the 2018 laboratory reform are now probably priced in.This reform essentially involved stricter budgeting by office-based physicians.After leaving this through immunochemistry,microbiology and infectious immunology were the growth drivers in 2019.In contrast,the rapid test market shows a decline of 5.6%.The gap in growth in these market segments has widened in 2019.Again,the decline in the market for blood glucose test strips(-6.4%)dominates the entire rapid test market.However,this should be offset by significant growth in sensor-based glucose measurement(FGM,CGM)which cannot be shown in the data.From 2020,the total IVD market will additionally be reported without the diabetes self-management segment.This further increases the informative value of the data reports.”-VDGH,German IVD industry associationItaly -2.0%IVD MARKET 1556 M EUR Italian IVD market remains almost unchanged with slight decline of 2%during 2019 and only 0.5%if we exclude glucose tests.Compared to the previous year,the 2019 clinical chemistry sales decreased by 7.6%,mainly due to contraction of the public healthcare expenditure.Public buyers followed harsh cost containment strategies,and an ongoing reorganisation taking place in the public labs.The immunochemistry market grew by 3.9%,caused largely by increased testing in hormone and cardiac markers,as well as tests for autoimmune diseases and cancer.The haematology segment decreased by 2.7%.,while a 6.9%drop of sales occurred in microbiology,infectious diseases,and genetic testing.In 2019,strategies by the Regions continued to be focused on controlling public expenditure for IVDs.The lines of these policies were:(i)usually many biddings were equal as in the previous years;(ii)many Regions approved laws to reduce the number of tests in private labs(in many cases,a patient could have tests taken in a private labs but still reimbursed by the NHS),and such tests have to be done by only public labs(usually with long queues);(iii)the Government was not able to design its own governance strategies on medical devices and IVD,and the goal was to reduce it.Confindustria Dispositivi Medici,Italian IVD industry associationSpain 2.8%IVD MARKET 1033 M EUR“Mainly price-driven market and mild growth thanks to innovative tests.Growth in immunochemistry,micro and infectious diseases.Aggregated purchasing for the region and consolidation of laboratories remains a strong tendency but there is not too much extra-room for consolidation.Most laboratories have already consolidated and are looking for economies of scale and homogenization of the regions procedures and technologies.Customers are looking for new contracts based on risk sharing or value based considerations but the implementation of this kind of contracts is still only testimonial.Costs are increasing for automation and digitalization that reach almost every lab.Very automated market.Introduction of innovative technology or new tests remains slow due to a very heterogeneous market with 17 autonomous regions with different technology incorporation processes and purchase approaches.There is no central process to incorporate new technologies.Innovation is accepted but in a scenario where prices remains blocked and cost increases are seldom accepted.Continuous monitoring of Glucose is reimbursed in all regions subject to individual approval.Other glucose test strips suffers a commoditization approach.Evolution of POC lacking of a clear model of reimbursement and we dont see a significant improvement in the near future.”FENIN,Spanish IVD industry associationFrance 0.3%IVD MARKET 1624 M EUR “The Central Laboratory IVD French market is estimated at 1.624 billion,with a growth of 0.3%compared to 2018.The Central Laboratory IVD French market has been in stagnation since 2014 with continuous non-significant growth of less than 1%.”SIDIV,French IVD industry associationPoland 4.4%IVD MARKET 394 M EUR“Compared to the previous year,the Polish market observed an increase of 4.4%.”MedTech Polska,Polish IVD industry associationUnited Kingdom 3.1%IVD MARKET 1042 M EUR“The UK IVD market grew by 3.1%during 2019,of which a significant component was instruments and consumables.This could be in part due to increased reporting of these groups.Reagent revenues increased by 1.1%and there was particularly strong growth in Infectious Disease testing revenues.It is difficult to avoid commenting on 2019 without mentioning the current situation in the midst of the 2020 Covid-19 epidemic,but as the Influenza season was mild,it may have contributed to a lack of preparedness for mass testing later.At the time,however,the major concern was still Brexit and its likely impact on supply chains and market access.As expected,nucleic acid testing systems continue to grow strongly,by about 12m(17%)over 2018,and multiple target NAT infectious disease systems grew by 32%.Some individual tests declined surprisingly,such as Vitamin D,while allergy and autoimmune testing saw double digit percentage growth.Overall,the UK still spends a very low amount per capita on IVD testing.”-BIVDA,British IVD industry associationPortugal 1.5%IVD MARKET 226 M EUR“IVD market in Portugal has been quite stable,showing a negative development of-1.5%when compared with 2018.The market excluding glucose strips,has been stable,with a growth of 0.4%.The cause of the-1.5%market growthis that we are seeing a shift towards new technologies.In 2019,test strips declined around 4%.Short term tendering and contracts adding to political measures to contain costs in Healthcare,specifically with Medical Devices,leads to high pressure on prices.Slight market positive development from organic growth(higher life expectancy and increase in elderly population)is being compensated by market value decrease with cost measures and aggressive competitive pressure.Public funding is leaning towards more cost-effective and integrated care,with and increasing role of insurance companies.Health insurance continues to gain relevance with 25%of population insured(growth 4.5%)and a growing number of private hospitals competing aggressively to gain MS.Lab consolidation seen in the past has slowed down with stabilization of number of labs in the country.Weve been witnessing increasing patient empowerment and education,with a shift of disease management from reactive to preventive.Public policies are focused at improving screening and integrating hospitals and primary care.NHS purchasing centralization continuous to be discussed although not yet applied to IVD.Discussions are arising on new models of funding healthcare,like value-based purchasing and payments over results in health.”APIFARMA,Portuguese IVD industry associationGreece 7.5%IVD MARKET 213 M EUR“2019 was the first full year during which the Greek Government was able to define its fiscal policy outside the fiscal adjustment programmes since 2010.The Greek economy grew for the third consecutive year,with 1.9%GDP growth compared to 2018.The Greek IVD market grew by 7.5%in 2019,for the fourth consecutive time since 2008,reaching a size of 213M.This growth is driven mainly from the public sector,which represents 67%of the Greek IVD market.The remaining 33%corresponds to the private sector.Finally,for the total IVD Market,DSO were approximately 230 days during 2019.”SEIV,Greek IVD industry associationSlovenia 0.1%IVD MARKET 52 M EUR“The market stayed at last years level,only 0.1%growth.The reason is mainly the decline of the Rapid testing and Diabetes Care market by almost-4%and slowing down of the Laboratory market growth.Reagents sales were declining approximately-2%due to Clin Chemistry(-3%),Haematology/Haemostasis(-4%),and a big drop in Infect.Immunology(-14%),all being partially compensated by Immunology Reagents sales by 6%.To last years outstanding contribution of the Instruments sales to the market value,the trend continued by 8%growth in 2019(importantly by Immunochemistry&Infectious Immunology Instruments)and after-sales Service.As the public procurement system is still very much based on price,no significant increase in the market value is expected.”SIEDMA,Slovenian IVD industry associationAustria 2.3%IVD MARKET 268 M EUR“In 2019,the Austrian IVD market grew by 2.3%,reaching a market size of 268 M Euros.”AUSTROMED,Austrian IVD industry association Slovakia 1.9%IVD MARKET 77 M EUR“IVD market in Slovakia has been quite stable,showing a growth of 1.9%when compared with 2018,mainly caused by NAT testing in Blood Banks.”SEDMA,Slovakian IVD industry associationDataGatheringParticipating in the GDMS programmeNot participating in the GDMS programmeThe results presented above are based on individual 2019 estimates made for 28 countries,comprising of the EU countries,EFTA countries and Turkey:13 countries are participating in the Global Diagnostic Market Statistics(GDMS,former EDMS)programme:Austria,Belgium,Czech Republic,France,Germany,Italy,the Netherlands,Poland,Portugal,Slovakia,Spain,Switzerland,and the UK.The National Association Members of MedTech Europe and the MedTech Europes Market Research Committee have estimated the IVD market in 17 other countries not participating in the GDMS programme:Bulgaria,Croatia,Cyprus,Denmark,Estonia,Finland,Greece,Hungary,Iceland,Ireland,Latvia,Lithuania,Malta,Norway,Romania,Slovenia,Sweden.The figures per country are compiled from the Global Diagnostic Market Statistics(GDMS)programme,through which companies report invoiced sales of reagents,instruments and consumables to an independent auditor,CIP,as based on the Global IVD Classification(GIVD).This is done in association with the MedTech Europes Market Research Committee and the National Association Members.More than 85%of the market is covered in major countries by GDMS,ensuring the reliability and objectiveness of the information provided by MedTech Europe and its members.MedTech Europe encourages all IVD suppliers and countries to participate in the GDMS programme,which is the largest In vitro diagnostic audit in Europe and the most accurate source of information for understanding and predicting market trends.About In Vitro Diagnostics In vitro diagnostics are non-invasive tests performed on biological samples(for example blood,urine or tissues)to diagnose or exclude a disease.IVDs provide valuable information about how the body is functioning and its state of health.They are used for diagnosis,prognosis,risk stratification,screening and therapeutic monitoring of diseases.IVDs have a broad scope ranging from sophisticated technologies performed in clinical laboratories to simple self-tests,such as those for pregnancy and glucose monitoring.About MedTech Europe MedTech Europe is the European trade association for the medical technology industry including diagnostics,medical devices and digital health.Our members are national,European and multinational companies as well as a network of national medical technology associations who research,develop,manufacture,distribute and supply health-related technologies,services and solutions.MedTech Europes mission is to make innovative medical technology available to more people,while helping healthcare systems move towards a sustainable path.MedTech Europe encourages policies that help the medical technology industry meet Europes growing healthcare needs and expectations.It also promotes medical technologys value for Europe focusing on innovation and stakeholder relations,using economic research and data,communications,industry events and training sessions.The European in vitro diagnostic industry is a market worth around 11 billion.Driven by research and development,95%of the industry is comprised of small and medium size enterprises and approximately 1 billion euros per year is reinvested in R&D.Developed by MedTech Europe,the Global Diagnostic Market Statistics(GDMS)and Management Information System(MIS)programmes provide a comprehensive overview of the latest market trends based on the Global IVD Product Classification(GIVD).For more information,visit www.medtecheurope.org.For more informationTeodora Angelova Market Data ManagerEmail:t.angelovamedtecheurope.orgwww.medtecheurope.orgPhone: 32 2 777 02 74www.medtecheurope.org

2021-03-13 13页 5星级

ICCT：越南的两轮摩托车：2019及2020年车队特征及燃料消耗量基准分析（2022）（英文版）（19页）.pdf

FEBRUARY 2022WORKING PAPER 2022-08Two-wheelers in Vietnam:A baseline analysis of fleet characteristi.

2021-03-13 19页 5星级

世界卫生组织（WHO）：2021-2030年被忽视的热带病路线图：实现可持续发展目标（英文版）（196页）.pdf

2021-2030年被忽视热带病路线图是世卫组织预防、控制以及在可行情况下消除和根除被忽视热带病的第二份蓝图。它遵循了2012年发布的第一个路线图，即加速克服被忽视热带病的全球影响(1)，该路线图为随.

2021-03-12 196页 5星级

莱坊国际（Knight Frank）：2021年财富报告（第15版）（英文版）（88页）.pdf

在那些表示其超高净值客户财富增加的受访者中，出现了三个关键主题来解释原因:多元化、股票和房地产。遵循技术崛起等趋势的长期投资策略的多元化投资组合，使得某些领域的亏损可以被其他领域的增长所抵消。无论是跨.

2021-03-12 85页 5星级

气候政策倡议组织：改善亚洲财政刺激的影响：绿色复苏投资及机会分析报告（英文版）（48页）.pdf

虽然早期应对新冠肺炎大流行的重点是救援工作，但各国政府目前正在向经济复苏努力过渡。本报告分析的五个亚洲国家印度、印度尼西亚、菲律宾、新加坡和韩国自2020年2月疫情爆发以来，已宣布总计8,840亿美元的新冠肺炎复苏刺激计划。但是，这些公共投资在实现长期、可持续的增长方面能发挥多大的作用呢?与常规的经济刺激措施相比，绿色刺激措施已被证明既能带来短期经济收益，也能在长期内积累国家财富。绿色复苏措施，如投资于可再生能源、低排放运输、能源效率以及基于自然的缓解和适应解决方案，比寻求支持老龄化、污染更严重的生产方式的政策，提供了更高的就业强度，以及其他经济回报和更广泛的社会效益。依赖自然资本枯竭、加速气候危机的增长模式是不可持续的，因为排放严重、对环境有害的商业模式现在面临着原材料枯竭、需求减少、最终金融资产搁浅的风险。恢复自然和生物多样性、积极向可再生能源转型以及投资可持续基础设施都是就业密集型活动，可以帮助受经济危机重创的地区，同时也有助于各国实现气候目标。气候行动财政部长联盟强调，在立即采取行动管理危机之后，政策制定者需要设计和实施复苏战略，支持中长期可持续增长。

2021-03-12 48页 5星级

世界卫生组织（WHO）：南苏丹集群间饥荒应对策略案例研究（英文版）（43页）.pdf

在复杂的危机中，人道主义反应必须跨越许多部门，因此，集群间协作是最佳办法。例如，南苏丹人民经历的饥荒和营养不良是各种因素和事件交汇的结果。多年来，受影响的人口受到许多冲击和发展不足。该国仍处于前所未有.

2021-03-12 43页 5星级

Start Network：COVID-19对萨赫勒地区环境迁移的影响（英文版）（38页）.pdf

萨赫勒地区被称为人为气候变化的热点地区，面临着缓慢的气温上升和突然的极端天气冲击，如洪水和干旱。迁徙长期以来一直是萨赫勒人口的特征，人们迁徙是为了减轻环境退化造成的影响，除其他外，还受到气候变化的影响，并使获得生计来源的途径多样化，这些生计来源仍然以农业活动和自然资源为基础。该地区于2020年3月出现了第一例确诊的COVID-19病例。各国政府迅速采取行动，实施行动限制，关闭国际边界和实施局部封锁，都是为了限制病毒的传播。然而，随着病毒的传播，长期存在的季节性移徙模式受到限制，使整个区域数百万萨赫勒人的一个重要补充收入来源暂时搁置。本报告旨在评估这些限制对环境移民近期、中期和长期生活的影响。本研究由REACH与Start网络合作进行，作为其移民应急基金的一部分，旨在增进对萨赫勒地区移民、气候变化和COVID-19之间相互联系的了解，旨在提高启动机制网络成员机构和捐助界应对这场危机的能力。这项研究的结果借鉴了广泛的二次数据审查、移民专家、人道主义和发展工作者的知识。最重要的是，调查结果利用了在布基纳法索、尼日利亚和尼日尔对该地区季节性移民进行的135次个人面谈，其中包括布基纳法索、尼日利亚和尼日利亚移民和非移民。

2021-03-12 38页 5星级

AEVI：地中海国家的下一代商家收购新趋势报告（英文版）（21页）.pdf

在金融科技和支付创新的推动下，欧洲正在经历支付行业的复兴。传统的参与者正在被颠覆，而新的市场进入者抓住了机会，迅速获得市场和消费者钱包的份额。该行业正处于一个不断变化的时期，在欧洲这个充满不确定性的时期，了解趋势和地域变得越来越重要。本报告旨在阐明在快速变化影响商家收购的新趋势。具体来说，我们关注西班牙、意大利和法国等个别市场的下一代收购。研究的总体目标是，它可以用于设计战略，以适应市场和全球水平的商业趋势。随着5G的出现，对服务和实时数据的更快接入带来了希望，随着智能设备的使用和连接只会继续激增，需求将进一步增加。智能手机正以惊人的速度在全球普及，金融科技提供商正从中受益：如今，全球连接到移动服务的人数已超过50亿，预计到2025年，移动用户将达到59亿，相当于全球人口的71%。到2022年，欧洲移动技术和服务的产值预计将占该地区GDP的4.1%，达到7200亿欧元。随着智能手机连接的增加，支付技术必须发展，以满足需求的快速变化。电子商务和在线零售是支付创新的驱动力，平板电脑、智能手机、云计算、分析和社交媒体等技术促进和推动了变革。总的来说，消费者越来越善于理解无缝支付体验是如何运作的，以及它们为日常购买活动带来的优势。无收银员商店和自动支付服务等行业的发展极大地改变了消费者对“无摩擦”支付的期望。

2021-03-11 21页 5星级

OpenGroup：Revolut多币种信用卡使用研究报告（英文版）（24页）.pdf

Revolut是一家创立于英国的金融科技初创公司，旨在从全球传统银行赢得客户。它提供数十种货币的维萨卡和万事达卡账户。持卡人可以在账户间转账，不收取银行手续费，而且利率优惠。.

2021-03-11 24页 5星级

益普索（Ipsos）：2021世界担忧调查（英文版）（16页）.pdf

全球汇总：2021年1月冠状病毒连续第十个月成为全球关注的焦点。最新结果显示，27个国家50%的人认为COVID-19是他们国家目前面临的最令人担忧的问题之一，这是自去年5月以来的最高水平。与此同时，.

2021-03-11 16页 5星级

世界卫生组织（WHO）：世卫组织对新冠疫情的反应-年终回顾（英文版）（66页）.pdf

COVID-19大流行是我们这个时代最严重的危机，夺走了200多万人的生命，对全球经济造成了二战以来最大的冲击。许多国家为控制病毒而实行的社会和经济限制暴露并加剧了不平等现象。在实现可持续发展目标方面.

2021-03-11 66页 5星级